课题基金 / 基金详情

Developing Functional Ferritin Nanocages for Blood Brain Barrier Traversing and Cellular Delivery

Developing Functional Ferritin Nanocages for Blood Brain Barrier Traversing and Cellular Delivery
开发用于血脑屏障穿越和细胞递送的功能性铁蛋白纳米笼
批准号:
2001606
负责人:
Xiaoyang Xu
金额:
$34.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-04-30

项目摘要

项目成果

Xiaoyang Xu的其他基金

相似基金

相关文献

中文摘要
翻译
血脑屏障位于中枢神经系统和外周血液循环之间,阻止潜在的毒素进入大脑,但也抑制了药物的成功输送。这阻碍了对阿尔茨海默氏症、帕金森氏症和脑癌等与大脑相关的致命疾病的有效成像、诊断和治疗。因此,对能够解决这些问题并有效治疗脑部疾病的递送系统的需求巨大。天然物质,如铁蛋白,已被证明可以自组装成纳米笼子,并跨越血脑屏障。然而,对这些纳米笼如何穿过屏障进入大脑以及它们的结构-功能关系的完整理解仍然难以捉摸。这项研究项目将结合生物工程和化学方法,了解这些纳米结构如何与血脑屏障相互作用,并合理设计具有跨越血脑屏障和实现细胞递送能力的纳米笼。该项目将为研究纳米材料-生物屏障相互作用提供一个强大的纳米颗粒工具,并将推动下一代脑部药物输送和成像平台和技术的发展。该项目汇集了几个关键技术领域,包括纳米材料、化学工程、细胞生物学和生物医学工程,为不同群体的研究生和本科生提供跨学科培训,并让当地高中的学生接触尖端研究。该研究项目的中心目标是以铁蛋白为模型蛋白质,实现对基于蛋白质的纳米笼/血脑屏障相互作用的全面了解,并随后利用这一知识开发一种新的蛋白质纳米笼家族,作为脑靶向、模块化递送平台,并按需提供附加功能。核心假设是,通过合理的设计,工程铁蛋白可以保持其组装成纳米笼的能力,穿过血脑屏障的生物界面,并被赋予靶向递送、装载治疗和/或显像剂的新能力。该研究项目旨在:1)设计并从基因上引入铁蛋白的靶向结构域,将铁蛋白组装成铁蛋白纳米笼;2)利用细胞模型研究纳米笼穿越血脑屏障和细胞靶向的能力;以及3)研究纳米笼结构与生物功能的关系。该项目的范围包括探索蛋白质纳米笼与生物系统的相互作用,以阐明遗传指导的纳米级模块设计,并提供许多脑部疾病潜在治疗的诊断数据。该项目的最终目标是开发一种经过基因设计和化学工程的纳米级递送系统,可以通过无法穿透的血脑屏障递送治疗和诊断药物。总体而言,这些实验将探索纳米尺度的传输机制,并探索工程纳米笼与生物系统之间的相互作用,从而为设计和生产基于蛋白质的治疗系统的新范式奠定基础。这项建议的教育部分将包括来自代表性不足群体的青年,目标是吸引、激励和培训下一代STEM专业人员。该奖项反映了NSF的法定使命,并通过使用基金会的智力优势和更广泛的影响审查标准进行评估,被认为值得支持。
英文摘要
The blood-brain barrier stands between the central nervous system and peripheral blood circulation, preventing entry of potential toxins into the brain but also inhibiting the successful delivery of drugs. This prevents the effective imaging, diagnosis and treatment of deadly brain-related diseases such as Alzheimer’s, Parkinson’s disease and brain cancer. As such, there is a tremendous demand for delivery systems which can solve these problems and effectively treat brain disease. Natural materials such as ferritin proteins have been shown to self-assemble into nanocages and cross the blood-brain barrier. However, a complete understanding of how these nanocages move across the barrier into the brain as well as their structure-function relationships has remained elusive. This research project will combine bioengineering and chemical approaches to understand how these nanostructures interact with the blood-brain barrier and to rationally design nanocages which have the capability to cross blood-brain barriers and to achieve cellular delivery. The project will provide a robust nanoparticle tool to study nanomaterial-biological barrier interactions and will advance the science for the development of next generation brain drug delivery and imaging platforms and techniques. This project brings together several key technology areas, including nanomaterials, chemical engineering, cell biology and biomedical engineering, providing interdisciplinary training for a diverse group of graduate and undergraduate students as well as exposing students from local high schools to cutting-edge research. The central goal of the research project is to achieve a comprehensive understanding of protein based nanocage/blood-brain barrier interactions using ferritin as a model protein and subsequently to use this knowledge to develop a novel family of protein nanocages as brain targeted, modular delivery platforms with additional functionalities available on demand. The central hypothesis is that with rational design, the engineered ferritin protein can maintain its ability to assemble into nanocages, cross the biological interface of the blood-brain barrier, and also be conferred with new abilities for targeted delivery, loading of therapeutics and/or imaging agents. The research project seeks to: 1) design and genetically introduce targeting domains to ferritin proteins, assemble the ferritin proteins into ferritin nanocages, 2) investigate the nanocages’ blood-brain barrier traversing and cellular targeting capabilities using cellular models; and 3) study the nanocage structure-biological function relationship. The scope of the project includes probing protein nanocage interactions with biological systems to elucidate the genetically-directed nanoscale modular design and providing theragnostic data on the potential treatment of many brain diseases. The ultimate goal of the project is to develop a genetically designed and chemically engineered nanoscale delivery system which can deliver therapeutic and diagnostic agents across the impenetrable blood-brain barrier. Overall, the experiments will probe nanoscale transport mechanisms and explore the interactions between engineered nanocages and biological systems, therefore laying the foundation for design and production of a new paradigm of protein-based theranostic systems. The educational components of this proposal will involve youth from underrepresented groups with a goal to attract, inspire and train the next generation of STEM professionals.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Rational design of engineered H-ferritin nanoparticles with improved siRNA delivery efficacy across an in vitro model of the mouse BBB
合理设计工程化 H-铁蛋白纳米粒子,在小鼠 BBB 体外模型中提高 siRNA 递送效率
DOI: 10.1039/d1nr07880a
发表时间: 2022
期刊: Nanoscale
影响因子: 6.7
作者: [Yuan, Ziwei, Wang, Bin, Teng, Yilong, Ho, William, Hu, Bin, Boakye-Yiadom, Kofi Oti, Xu, Xiaoyang, Zhang, Xue-Qing]
通讯作者: Zhang, Xue-Qing
DOI: 10.1021/acsnano.2c07822
发表时间: 2022-10-21
期刊: ACS NANO
影响因子: 17.1
作者: [Li, Zhongyu, Zhang, Xue-Qing, Xu, Xiaoyang]
通讯作者: Xu, Xiaoyang
I-Corps: Nanomedicine as Treatment for Drug-Resistant Bacteria
  • 批准号:
    1723667
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2017
  • 负责人:
    Xiaoyang Xu
  • 依托单位:
国内基金
海外基金
Identification and quantification of primary phytoplankton functional types in the global oceans from hyperspectral ocean color remote sensing
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    160万元
  • 批准年份:
    2022
  • 负责人:
    李忠平
  • 依托单位:
高维数据的函数型数据(functional data)分析方法
  • 批准号:
    11001084
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    16.0万元
  • 批准年份:
    2010
  • 负责人:
    周迎春
  • 依托单位:
Multistage,haplotype and functional tests-based FCAR 基因和IgA肾病相关关系研究
  • 批准号:
    30771013
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2007
  • 负责人:
    王一鸣
  • 依托单位: